According to the significant downregulation of FAM175B expression in ESCC and HGIEN tissues, we suggested that FAM175B has great potential as a biomarker for early diagnosis and prognosis in ESCC. This evidence concerns the gene ABRAXAS2 and esophageal squamous cell carcinoma.